PlainRecalls

Genentech, Inc.

Compiled from official public sources by the publisher.

11 recalls on record · Latest: Jun 5, 2024

Subscribe to new Genentech, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Genentech, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,346 of 14,151 · 11 notices · 0.011% archive

  • BOOK 11 notices
  • RANK #1,346 of 14,151
  • SHARE 0.011% archive
  • AGENCY FDA Drug (11)
  • CAT drugs
  • CATS 2 categories
  • LATEST Jun 5, 2024
  • PHOTO Agfa Corp.

Nearest notice-volume peer: Agfa Corp. (0 notice gap)

Genentech, Inc. accounts for about 0.011% of the 104,423-notice archive on 11 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Genentech, Inc. compares to 14,151 recalling firms

Genentech, Inc. ranks 1,346th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Genentech, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

11 1346th of 14151 higher than 12,735 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Genentech, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Genentech, Inc. holds about 0.011% of archive notices alongside 11 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jun 5, 2024

Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64
FDA Drug Low Nov 9, 2022

Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One Susvimo initial fill needle, NDC 50242-078-55; and b) carton labeled as Susvimo Ocular Implant with Insertion Tool Assembly, containing One carrier with implant and One insertion Tool, UDI 81004259001, GTIN 00810042590014, Rx only, Genentech, Inc., A Member of the Roche Group, South San Francisco, CA 94080-4990.
FDA Drug Moderate Jul 14, 2021

Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Subcutaneous Use. Single-Dose Prefilled Syringe. Product of France, Manufactured by: Genentech, Inc. A Member of the Roche Group, South San Francisco, CA 9480-4990. NDC: 50242-215-01
FDA Drug Low May 5, 2021

Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05
FDA Drug Low Feb 21, 2018

Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01
FDA Drug Critical Sep 27, 2017

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27
FDA Drug Moderate Apr 12, 2017

Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01.
FDA Drug Critical Jan 30, 2013

Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic Water for Injection, USP (1.1% benzyl alcohol), Manufactured by Hospira, Inc., for Genentech, Inc., South San Francisco, CA 94080-4990, NDC 50242-903-69; and 1 Reconstitution Instructions per kit; Investigation Use only, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990.
FDA Drug Low Dec 26, 2012

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.
FDA Drug Moderate Dec 12, 2012

Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0076-01
FDA Drug Moderate Dec 12, 2012

Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0074-01

Genentech, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (11 here — thin-book).

Agfa Corp. 11 Akron Pharma, Inc. 11 Amendia, Inc 11 Aniara Diagnostica LLC 11 Arg Laboratories, Inc. 11

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Akron Pharma, Inc. 11 Arg Laboratories, Inc. 11 Bell Pharmaceuticals, Inc 11 Cipla 11

Frequently Asked Questions

How many federal recall notices name Genentech, Inc.? ▼
PlainRecalls indexes 11 distinct federal recall events naming Genentech, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Genentech, Inc. sit among other recalling firms? ▼
Genentech, Inc. ranks #1,346 of 14,151 by distinct recall-event count among 14,151 firms in this archive (90th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Genentech, Inc.'s notices? ▼
FDA Drug accounts for 11 of this firm's 11 indexed notices.
What product category dominates Genentech, Inc.'s filing book? ▼
Filings for Genentech, Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Genentech, Inc.: 11 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Genentech, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026